Verastem Oncology (VSTM) – Analyst Comments
-
BTIG Assumes Verastem (VSTM) at Buy
-
B.Riley Starts Verastem (VSTM) at Buy, "Verastem’s combo regimen is poised for strong market penetration"
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VSTM Stock Lookup